Quick Answer
Immuneering Corp reported Total Assets of $231.99 million for fiscal year 2025.
Immuneering Corp Total Assets — Annual History
| Fiscal Year | Total Assets | YoY Change |
|---|---|---|
| 2025 | $231.99M | +340.1% |
| 2024 | $52.71M | -48.6% |
| 2023 | $102.58M | -16.2% |
| 2022 | $122.37M | -26.6% |
| 2021 | $166.70M | +333.9% |
| 2020 | $38.42M | — |
Quarterly Total Assets
| Quarter Ending | Total Assets | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $241.06M | — | +501.8% |
| June 30, 2025 | $40.06M | -48.0% | -21.0% |
| March 31, 2025 | $50.68M | -42.4% | -3.9% |
| December 31, 2024 | $52.71M | -48.6% | -31.6% |
| June 30, 2024 | $77.09M | -38.3% | -12.4% |
| March 31, 2024 | $87.98M | -18.3% | -14.2% |
| December 31, 2023 | $102.58M | -16.2% | -9.9% |
| September 30, 2023 | $113.88M | -14.8% | -8.8% |
- Immuneering Corp showed an increase of +340.1% in Total Assets compared to the prior fiscal year.
- Over the 2020–2025 period, Immuneering Corp’s total assets has grown by 503.8% (from $38.42 million to $231.99 million).
- The most recent figure is from Immuneering Corp’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 6, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: